Cancer and Immune Checkpoint Inhibitor Treatment in the Era of SARS-CoV-2 Infection.

MLA

Gambichler, Thilo, et al. “Cancer and Immune Checkpoint Inhibitor Treatment in the Era of SARS-CoV-2 Infection.” Cancers, vol. 12, no. 11, Nov. 2020, p. 3383. EBSCOhost, https://doi.org/10.3390/cancers12113383.

APA

Gambichler, T., Reuther, J., Scheel, C. H., Susok, L., Kern, P., & Becker, J. C. (2020). Cancer and Immune Checkpoint Inhibitor Treatment in the Era of SARS-CoV-2 Infection. Cancers, 12(11), 3383. https://doi.org/10.3390/cancers12113383

Chicago

Gambichler, Thilo, Judith Reuther, Christina H. Scheel, Laura Susok, Peter Kern, and Jürgen C. Becker. 2020. “Cancer and Immune Checkpoint Inhibitor Treatment in the Era of SARS-CoV-2 Infection.” Cancers 12 (11): 3383. doi:10.3390/cancers12113383.